This short report uses data on drug-related emergency department (ED) visits from the Drug Abuse Warning Network to look at 2011 ED visits involving synthetic cannabinoids. It shows trends compared to 2010 by gender, age group, the age distribution of patients, the drugs most commonly combined with synthetic cannabinoids and...
Search Results
This report presents an evaluation of the coverage, overlap, biases, strengths, and weaknesses of three sources of data on the receipt of specialty substance use treatment: the National Survey on Drug Use and Health (NSDUH), the National Survey of Substance Abuse Treatment Services (N-SSATS), and the Treatment Episode Data Set...
This issue of The CBHSQ Report presents facts about substance use among young adults, including initiation, receipt of treatment, and emergency department visits for substance use \
This Drug Abuse Warning Network (DAWN) short report looks at the estimated number of emergency room visits for adverse reactions involving involving the prescription sleep qie zolpidem for 2005 through 2010. The report focuses on gender, age groups and other pharmaceuticals such as pain relievers, other anti-anxiety and insomnia medications...
This Drug Abuse Warning Network (DAWN) short report summarizes key findings about drug-related emergency department visits between 2004 and 2011. The report includes data for illicit drugs, alcohol, and prescription and over-the counter medications. For medications, the report looks at misuse and abuse, adverse reactions, and accidental ingestion of drugs...
This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,
This Drug Abuse Warning Network (DAWN) short report is about emergency department visits involving energy drinks (beverages containing caffeine and vitamins/minerals) from 2007 to 2011.